Health and pharmaceutical stocks — including Moderna (MRNA), Pfizer (PFE), BioNTech (BNTX), Novavax (NVAX) — are under pressure on Tuesday after ... for the stock. The average of price targets ...

Shares of Novavax Inc. NVAX slipped 1.69% to $8.13 Friday, on what proved to be an all-around poor trading session for the ...

Shares of vaccine stocks are trading lower after ... stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.

Novavax (NVAX ... stock's future direction? Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate ...

Shares of Novavax (NVAX) have gained 3.5% ... reason to expect an upside in the stock. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and ...

Shortly after President ... Should NVAX stock experience some wobbles, there may still be a decent chance of the security hitting the short call strike price. On the date of publication, Josh ...

The stock's fall snapped a two-day winning streak.

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store. Novavax (NVAX) witnessed a jump in share price last ...

Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ...